These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mescaline and lysergic acid diethylamide: therapeutic implications of the drug-induced state. Denber HC Dis Nerv Syst; 1969 Feb; 30(2):Suppl:23-7. PubMed ID: 5775311 [No Abstract] [Full Text] [Related]
3. [Therapeutic use of LSD 25 in clinical psychiatry]. JOST F Wien Klin Wochenschr; 1957 Sep; 96(36):647-51. PubMed ID: 13468477 [No Abstract] [Full Text] [Related]
4. [Clinical and physiological study of mescaline sulfate- and lysergic acid-induced reactions in mental disorders]. LARICCHIA R; SANGUINETI I; ZAPPAROLI GC Riv Sper Freniatr Med Leg Alien Ment; 1956 Oct; 80(4):887-918. PubMed ID: 13390719 [No Abstract] [Full Text] [Related]
5. Further studies in the therapeutic value of lysergic acid diethylamide in mental illness. SANDISON RA; WHITELAW JD J Ment Sci; 1957 Apr; 103(431):332-43. PubMed ID: 13429304 [No Abstract] [Full Text] [Related]
6. Verbatim recording and transference studies with lysergic acid diethylamide (LSD-25). ABRAMSON HA J Nerv Ment Dis; 1957; 125(3):444-50. PubMed ID: 13481754 [No Abstract] [Full Text] [Related]
7. [Psycholytic psychotherapy]. Hausner M Act Nerv Super (Praha); 1968 Feb; 10(1):50. PubMed ID: 5728080 [No Abstract] [Full Text] [Related]
8. Some general observations on the usefulness of lysergic acid in psychiatry. Livingstone D N Z Med J; 1966 Oct; 65(410):657-65. PubMed ID: 4224461 [No Abstract] [Full Text] [Related]
9. A study of the effects of L.S.D.: physiologic and psychological changes and their interrelations. DIMASCIO A; GREENBLATT M; HYDE RW Am J Psychiatry; 1957 Oct; 114(4):309-17. PubMed ID: 13458494 [No Abstract] [Full Text] [Related]
10. [Psycholytic interval therapy with LSD 25 or ambulant psychoanalytical therapy?]. Derbolowsky U Z Psychother Med Psychol; 1966 Jan; 16(1):33-8. PubMed ID: 5911900 [No Abstract] [Full Text] [Related]
11. [Irrationality in psychiatry. III. New age]. Vacek J Cesk Psychiatr; 1991 Feb; 87(1):23-7. PubMed ID: 1913939 [No Abstract] [Full Text] [Related]
13. [Hallucinogens, a Troyan horse?]. van Praag HM Ned Tijdschr Geneeskd; 1968 Nov; 112(44):1985-9. PubMed ID: 5687139 [No Abstract] [Full Text] [Related]
14. [Pharmacotherapy and psychotherapy. LSD as an adjuvant in psychotherapy?]. Booij J Ned Tijdschr Geneeskd; 1968 Jan; 112(1):2-7. PubMed ID: 5691284 [No Abstract] [Full Text] [Related]
15. [Therapeutic community at the psychiatric department of a faculty hospital]. Hausner M Cesk Psychiatr; 1968 Aug; 64(4):241-5. PubMed ID: 5680672 [No Abstract] [Full Text] [Related]
16. Remarks on LSD and mescaline. HOCH PH J Nerv Ment Dis; 1957; 125(3):442-4. PubMed ID: 13481753 [No Abstract] [Full Text] [Related]
17. The hallucinogenic drugs--their use and abuse. Whitaker LH Med J Aust; 1968 Mar; 1(9):370-1. PubMed ID: 5646708 [No Abstract] [Full Text] [Related]
18. 'There is no armour against fate'. Walker MW Physiotherapy; 1973 Mar; 59(3):72-4. PubMed ID: 4790902 [No Abstract] [Full Text] [Related]
19. [Problems in psychotherapy]. Booij J Ned Tijdschr Geneeskd; 1968 Sep; 112(37):1621-4. PubMed ID: 4878451 [No Abstract] [Full Text] [Related]